Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China · Delayed Price · Currency is CNY 46.28
+1.23 (2.73%)
Oct 23, 2026, 3:00 PM CST
SHA:688513 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,336 | 1,331 | 1,350 | 1,117 | 1,171 | 1,023 |
Revenue Growth | 0.09% | -1.36% | 20.82% | -4.56% | 14.43% | 10.96% |
Gross Profit Gross Profit Growth | 1,004 | 995.18 | 1,005 | 890.18 | 971.4 | 876.62 |
Operating Income Operating Income Growth | 157.86 | 198.94 | 168.42 | 152.2 | 157.4 | 135.47 |
Net Income Net Income Growth | 277.24 | 284.06 | 238.23 | 226.57 | 246.52 | 232.43 |
Earnings Per Share EPS Growth | 1.60 | 1.63 | 1.36 | 1.28 | 1.39 | 1.32 |
EPS Growth | 23.08% | 19.85% | 6.25% | -8.22% | 5.68% | 8.98% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Northeast China Region Northeast China Region Growth | 58.86 |
Northern China Northern China Growth | 212.86 |
East China East China Growth | 476.68 |
Southern China Southern China Growth | 164.98 |
Central China Region Central China Region Growth | 92.99 |
Northwestern Region Northwestern Region Growth | 37.56 |
Southwest Region Southwest Region Growth | 253.79 |
Overseas Regions Overseas Regions Growth | 31.38 |
Total Total Growth | 1,329 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,673 | 1,613 | 1,424 | 1,523 | 1,347 | 1,505 |
Total Debt Total Debt Growth | 148.75 | 146.65 | 114.04 | 223.48 | 105.29 | 20.02 |
Net Cash (Debt) Net Cash Growth | 1,524 | 1,467 | 1,310 | 1,300 | 1,242 | 1,485 |
Net Cash Growth | 7.91% | 11.99% | 0.78% | 4.63% | -16.33% | -6.35% |
Net Cash Per Share Net Cash Per Share Growth | 8.79 | 8.42 | 7.48 | 7.34 | 7.03 | 8.43 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 274.86 | 264.94 | 263.24 | 275.25 | 151.94 | 147.6 |
Capital Expenditures CapEx Growth | -93.57 | -86.28 | -117.42 | -175.26 | -339.33 | -270.19 |
Free Cash Flow Free Cash Flow Growth | 181.29 | 178.66 | 145.82 | 99.99 | -187.38 | -122.59 |
Free Cash Flow Growth | -28.79% | 22.52% | 45.83% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 75.13% | 74.75% | 74.42% | 79.68% | 82.99% | 85.70% |
Operating Margin | 11.82% | 14.94% | 12.48% | 13.62% | 13.45% | 13.24% |
Pretax Margin | 21.27% | 22.51% | 18.71% | 21.63% | 22.38% | 24.14% |
Profit Margin | 20.75% | 21.34% | 17.65% | 20.28% | 21.06% | 22.72% |
FCF Margin | 13.57% | 13.42% | 10.80% | 8.95% | -16.01% | -11.98% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.490 | 0.490 | 0.430 | 0.395 | 0.381 | 0.531 |
Dividend Per Share Growth | 13.95% | 13.95% | 8.97% | 3.57% | -28.19% | 159.97% |
Dividend Yield | 1.06% | 0.80% | 1.43% | 0.91% | 0.92% | 1.68% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.92 | 37.78 | 22.05 | 33.81 | 29.64 | 23.97 |
Forward PE | 27.64 | 36.07 | 16.21 | 25.33 | 22.56 | 20.69 |
P/FCF Ratio | 43.13 | 60.07 | 36.02 | 76.60 | - | - |
PS Ratio | 5.85 | 8.06 | 3.89 | 6.86 | 6.24 | 5.45 |